Christine Blasey Ford: Abortion Profiteer.
Supporters of Dr. Christine Blasey Ford’s vague and unsubstantiated charges, based on hazy memories, against SCOTUS pick Brett Kavanaugh have their mantras. One of them is “Women don’t lie!”
We should answer: “Ever heard of Asia Argento? How about Tawana Brawley? Those white Southern women who sent innocent black men to the gallows under Jim Crow?” The reply, of course, will be … crickets.
Their next, slightly subtler slogan is, “Why would she lie?” In other words, why turn her life upside down, and be subject to the same of kind of appalling death threats to which the Kavanaugh family now is subject?
Dr. Christine Blasey Ford profited directly from abortion.
One sane answer is: To control a seat on the U.S. Supreme Court. Candidates for office routinely lie to get a whole lot less. Zealots on single issues, such as abortion, sometimes kill people. What makes us sure that Ford isn’t such a zealot, maybe a real rape victim recruited to blame the wrong guy, for the Cause?
Anyway, he deserves it, as a privileged white male who might, just might, endanger “women’s reproductive health care access”? (That is, abortion on demand through all nine months of pregnancy.)
Follow the Money
But here’s an even more direct reason why Ford might be blaming the wrong guy for what happened to her: She has profited from an abortion drug. That’s right. As Natural News has reported, Ford
works for a pharmaceutical company that manufacturers an abortion pill drug, whose profits could be strongly impacted by future Supreme Court decisions on abortion rights.
Corcept Therapeutics (Corcept.com) manufacturers and markets an abortion pill drug called mifepristone, and Christine Blasey Ford is a co-author of at least eight published scientific papers produced by the pharmaceutical giant to promote its pills. You can see Blasey’s name listed on several publications at this Corcept.com web page detailing their research papers.
Corcept Therapeutics, Inc., a $166 billion market cap company (stock symbol CORT) reportedly has current annual sales of $216 million. The company offers just one drug, mifepristone, which is widely known as an “abortion pill” or RU-486.
The controversial site Gateway Pundit first broke this story. It seems to have all its facts straight. And it leaves out a key one: Ford actually worked as “director of biostatistics for Corcept Therapeutics in Menlo Park,” according to the San Francisco Chronicle. (H/T Tiger Droppings.)
Okay, so the one person with a remotely plausible story attacking Kavanaugh, whose story Democrats saved as a Hail Mary pass, turns out to have profited directly from an abortion drug. Imagine if an anti-gun SCOTUS appointee were just about to be confirmed. Then some right-wing woman came out with vague, unproveable charges? Then we learned that the accuser had worked for a company that made AR-15s. How much credence would the media give her? More crickets.
If anyone has the standing to question Ford in detail as to why she didn’t report the alleged assault for more than three decades, it’s Juanita Broaddrick.
Juanita Broaddrick Should Question Ford in the Senate
The Republicans should stand firm on their right to bring in outside counsel to question Dr. Ford. They’re smart to consider bright women lawyers, such as former Senator Kelly Ayotte. We don’t want this to just a bunch of guys questioning a woman’s attempted rape story, however shaky. But there’s one more person who should be there, even if it’s only to pose a question or two.
I mean Juanita Broaddrick, the Arkansas nurse who made far more credible, evidenced, timely rape charges against Bill Clinton. Who got waved off, mocked, and ignored by Clinton-sniffing media. And threatened by Hillary. As Broaddrick herself points out:
— Juanita Broaddrick (@atensnut) September 21, 2018
If anyone has the standing to question Ford in detail as to why she didn’t report the alleged assault for more than three decades, it’s Broaddrick. If the Republicans aren’t ready to play such hardball, they’re irresponsible fools, keen to lose.
Which of course is an open question.